Share ownership Aarti Drugs Limited

AARTIDRUGS

INE767A01016

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:48 10/04/2026 pm IST			5-day change	1st Jan Change
354.75 ^INR	-0.74%		+0.77%	-13.86%

07/03	Pinnacle Life Science Pvt. Ltd announced that it expects to receive INR 100 million in funding from Aarti Drugs Limited	CI
04/02	Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026

Share class: Aarti Drugs Limited

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	9,12,70,000	3,48,28,658 ( 38.16 %)	0	38.16 %

Major shareholders: Aarti Drugs Limited

Name	Equities	%	Valuation
Prakash Moreshwar Patil 9.624 %	87,83,869	9.624 %	35 M ₹
DSP Asset Managers Pvt. Ltd. 8.009 %	73,10,185	8.009 %	29 M ₹
Harshit Manilal Savla 4.737 %	43,23,269	4.737 %	17 M ₹
Rashesh Chandrakant Gogri 4.644 %	42,38,874	4.644 %	17 M ₹
Priti Prakash Patil 4.4 %	40,16,315	4.4 %	16 M ₹
Seema Harshit Savla 3.837 %	35,02,175	3.837 %	14 M ₹
Gogri Finserv Pvt Ltd. 3.795 %	34,63,971	3.795 %	14 M ₹
Hetal Gogri Gala 3.054 %	27,87,240	3.054 %	11 M ₹
Harit Pragji Shah 2.67 %	24,36,908	2.67 %	10 M ₹
Anushakti Enterprise Pvt Ltd. 2.622 %	23,92,696	2.622 %	10 M ₹
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Individuals	46.23%
Other	13.24%
Institutional	8.15%
Governments	0.69%
Unknown	31.69%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals	46.23%
India	22.05%
United Kingdom	0.02%

Based on 1000 largest holdings

Aarti Drugs Limited is an India-based company, which is engaged in manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates through pharmaceuticals segment. The Company's APIs products include iprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole, ofloxacin, and others. Its specialty chemicals includes benzene sulphonyl chloride, methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include alpha lipoic acid, itraconazole, ticagrelor, and sitagliptin. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited, and Pinnacle Chile SPA.

Employees

1,284

Sector

Pharmaceuticals

More about the company